Minesh P. Mehta, MD
Professor, Department of Human Oncology
School of Medicine and Public Health
University of Wisconsin
Roy A Patchell, MD
Chief of Neuro-Oncology
Professor of Neurosurgery and Neurology
University of Kentucky Medical Center
Michael A. Vogelbaum, MD, PhD
Associate Director, Neurosurgical Oncology
Brain Tumor and Neuro-Oncology Center
Cleveland Clinic Neurological Institute
Physician CME: 1.0
Podcast (MP3 & PDF)
CREDIT FOR THIS PROGRAM IS AVAILABLE FOR PHYSICIANS, ONLY.
In caring for patients with primary gliomas or metastatic brain tumors, there are few absolute standards of care and much controversy over which approaches are best. Is there just one optimal treatment modality for a particular patient? Are several different approaches reasonable? Are there novel solutions that merit further exploration? Our prestigious panel of experts in neuro-oncology, radiation oncology, and neurosurgery discuss the benefits and limitations of recent biological and clinical advances. Program Developer/Facilitator
. Target Audience
This educational activity is designed to meet the needs of neuro-oncologists, neurosurgeons, radiation oncologists, and medical oncologists interested in the treatment of primary and metastatic brain tumors.
Upon completion of this educational activity, the participant should be able to:
Discuss the benefits and limitations of surgery, radiosurgery, and chemotherapeutic approaches for primary gliomas as well as for metastatic brain tumors.
Differentiate between treatment approaches for single versus multiple metastases.
Describe current concepts regarding the potential role of biomarkers such as 1p/19q and MGMT.
Assess the local and systemic approaches for treating brain tumors with chemotherapy.
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by AKH prior to accreditation of the activity.
Dr. Mehta discloses advisory committee participation for Allos, product consultation for Pharmacyclics, and speakers’ bureau service for Schering-Plough. He intends to discuss unapproved/investigational uses of pharmacologic products or surgical devices.
Dr. Patchell claims no actual or potential conflict of interest to this program. He intends to discuss unapproved/investigational uses of pharmacologic products or surgical devices.
Dr. Vogelbaum discloses advisory committee and speakers’ bureau participation for Schering-Plough Corporation. He intends to discuss unapproved/investigational uses of pharmacologic products or surgical devices.
This educational activity may contain discussion of investigational uses of pharmaceutical agents or surgical devices. Some of these agents/devices may not have been approved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of AKH, Inc. and Medical Communications Media, Incorporated. AKH, Inc. is accredited by the ACCME to provide continuing medical education for physicians.
AKH, Inc. designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. Commercial Support Statements
Supported through an educational grant from Schering-Plough.
This program consists of a Podcast/MP3 audio file and a printable PDF of the post-test that can be submitted for credit and/or used to assist learning. You may play the audio online or download the file to an MP3 audio player, such as an iPod. You will also need Adobe Acrobat Reader to view and print the PDF post-test and evaluation.
Click on the "Start program" icon. This will bring you to the login/registration page where you will be able to register as a new CMEcorner.com member or check/revise existing registration information.
Update your existing registration information, if necessary. When ready, click on the "Continue to Program" icon at the top or bottom of the screen. This will take you to the podcast description page for CMEcorner2go.
Save the PDF file to your computer or open the file using the Adobe Acrobat Reader. Print a copy of the PDF, which includes the post-test and program evaluation. This can be used as a learning aid while you listen to the audio file.
Download or play the audio file by clicking on the appropriate button. Instructions for utilizing this program on a portable MP3 player such as an iPod can be found on this page.
Listen to the presentation before filling out the post-test and evaluation. It should take approximately 60 minutes to listen to the audio and complete the post-test and evaluation.
To receive CME credit, follow the link to the post-test. A CME statement will be awarded for a post-test score of 70% or better and by completing the evaluation. Successful completion of the post-test and evaluation online will enable you to immediately print a statement of credit. Alternately, complete the post-test and evaluation found on the last two pages of the PDF. Mail the pages according to the printed instructions. A CME statement will be awarded for a post-test score of 70% or better and by completing the evaluation. A certificate will be mailed within 6 weeks.
This CME activity is available at CMEcorner.com, GliomaEd.com and through iTunes. Submit the post-test only once for this activity to receive credit. Multiple statements will not be issued.
©2008 Medical Communications Media, Inc. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in the audio recording are those of the presenters and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, AKH Inc., or Schering-Plough. Any medications, diagnostic procedures, or treatments discussed by the program presenters should not be used by clinicians or other healthcare professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.